Providing high-quality care remotely to patients with rare bone diseases during COVID-19 pandemic

During the COVID-19 outbreak, the European Reference Network on Rare Bone Diseases (ERN BOND) coordination team and Italian rare bone diseases healthcare professionals created the "COVID-19 Helpline for Rare Bone Diseases" in an attempt to provide high-quality information and expertise on...

Full description

Saved in:
Bibliographic Details
Published inOrphanet journal of rare diseases Vol. 15; no. 1; p. 228
Main Authors Brizola, E, Adami, G, Baroncelli, G I, Bedeschi, M F, Berardi, P, Boero, S, Brandi, M L, Casareto, L, Castagnola, E, Fraschini, P, Gatti, D, Giannini, S, Gonfiantini, M V, Landoni, V, Magrelli, A, Mantovani, G, Michelis, M B, Nasto, L A, Panzeri, L, Pianigiani, E, Scopinaro, A, Trespidi, L, Vianello, A, Zampino, G, Sangiorgi, L
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 31.08.2020
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:During the COVID-19 outbreak, the European Reference Network on Rare Bone Diseases (ERN BOND) coordination team and Italian rare bone diseases healthcare professionals created the "COVID-19 Helpline for Rare Bone Diseases" in an attempt to provide high-quality information and expertise on rare bone diseases remotely to patients and healthcare professionals. The present position statement describes the key characteristics of the Helpline initiative, along with the main aspects and topics that recurrently emerged as central for rare bone diseases patients and professionals. The main topics highlighted are general recommendations, pulmonary complications, drug treatment, trauma, pregnancy, children and elderly people, and patient associations role. The successful experience of the "COVID-19 Helpline for Rare Bone Diseases" launched in Italy could serve as a primer of gold-standard remote care for rare bone diseases for the other European countries and globally. Furthermore, similar COVID-19 helplines could be considered and applied for other rare diseases in order to implement remote patients' care.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1750-1172
1750-1172
DOI:10.1186/s13023-020-01513-6